Sven Rohmann, CEO will be presenting @Immunicum at the upcoming European Life Sciences CEO Forum.
— Sachs Associates (@SachsAssociates) January 13, 2021
Immunicum is a clinical-stage biotech in immuno-oncology developing allogeneic, off-the-shelf, cell-based therapies for solid tumors.
More info @ https://t.co/YXBF2fUYBz pic.twitter.com/q3x7d1YlT8
